Sandra J. Horning is the retired Chief Medical Officer of Roche and has served as an independent director of Gilead since 2020. She brings significant leadership experience in the pharmaceutical and healthcare industry, including expertise in drug development across multiple therapeutic areas, and is a physician with experience treating patients as a practicing oncologist.